Chemomab Therapeutics CMMB
NASDAQ CMMB
$2.16 +0.09 (+4.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Shares Outstanding (Diluted) (2017 - 2025)

Chemomab Therapeutics (CMMB) Shares Outstanding (Diluted) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 64.41 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 115.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 138.28 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 556.90 Mn
10 Chemomab Therapeutics 13.62 Mn 3.25 Mn - 6.38 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 510.23 Mn
Sep 30, 2025 1.84 Bn
Jun 30, 2025 1.84 Bn
Mar 31, 2025 1.44 Bn
Dec 31, 2024 1.44 Bn
Sep 30, 2024 1.14 Bn
Jun 30, 2024 1.14 Bn
Mar 31, 2024 940.00 Mn
Dec 31, 2023 940.00 Mn
Sep 30, 2023 886.70 Mn
Jun 30, 2023 886.70 Mn
Mar 31, 2023 883.98 Mn
Dec 31, 2022 910.36 Mn
Sep 30, 2022 915.09 Mn
Jun 30, 2022 912.69 Mn
Mar 31, 2022 912.36 Mn
Dec 31, 2021 829.87 Mn
Sep 30, 2021 911.82 Mn
Jun 30, 2021 865.07 Mn
Mar 31, 2021 593,584.00